Vannetzel JM - Search Results

1

Myocardial ischemia and infarction associated with vinorelbine.

Bergeron A, Raffy O, Vannetzel JM. Bergeron A, et al. Among authors: vannetzel jm. J Clin Oncol. 1995 Feb;13(2):531-2. doi: 10.1200/JCO.1995.13.2.531. J Clin Oncol. 1995. PMID: 7844615 No abstract available.

2

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer.

Taylor SG 4th, Murthy AK, Vannetzel JM, Colin P, Dray M, Caldarelli DD, Shott S, Vokes E, Showel JL, Hutchinson JC, et al. Taylor SG 4th, et al. Among authors: vannetzel jm. J Clin Oncol. 1994 Feb;12(2):385-95. doi: 10.1200/JCO.1994.12.2.385. J Clin Oncol. 1994. PMID: 8113846 Clinical Trial.

3

Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity.

Lévi F, Benavides M, Chevelle C, Le Saunier F, Bailleul F, Misset JL, Regensberg C, Vannetzel JM, Reinberg A, Mathé G. Lévi F, et al. Among authors: vannetzel jm. J Clin Oncol. 1990 Apr;8(4):705-14. doi: 10.1200/JCO.1990.8.4.705. J Clin Oncol. 1990. PMID: 2179481 Clinical Trial.

4

Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysis.

Fontein DB, Seynaeve C, Hadji P, Hille ET, van de Water W, Putter H, Kranenbarg EM, Hasenburg A, Paridaens RJ, Vannetzel JM, Markopoulos C, Hozumi Y, Bartlett JM, Jones SE, Rea DW, Nortier JW, van de Velde CJ. Fontein DB, et al. Among authors: vannetzel jm. J Clin Oncol. 2013 Jun 20;31(18):2257-64. doi: 10.1200/JCO.2012.45.3068. Epub 2013 Apr 22. J Clin Oncol. 2013. PMID: 23610112

5

Circadian rhythm-modulated (CRM) chemotherapy of metastatic breast cancer with mitoxantrone, 5-fluorouracil, and folinic acid: preliminary results of a phase I trial.

Deprés-Brummer P, Berthault-Cvitkovic F, Lĕvi F, Brienza S, Vannetzel JM, Jasmin C, Misset JL. Deprés-Brummer P, et al. Among authors: vannetzel jm. J Infus Chemother. 1995;5(3 Suppl 1):144-7. J Infus Chemother. 1995. PMID: 8528975 Clinical Trial.

6

Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial.

Lévi FA, Zidani R, Vannetzel JM, Perpoint B, Focan C, Faggiuolo R, Chollet P, Garufi C, Itzhaki M, Dogliotti L, et al. Lévi FA, et al. Among authors: vannetzel jm. J Natl Cancer Inst. 1994 Nov 2;86(21):1608-17. doi: 10.1093/jnci/86.21.1608. J Natl Cancer Inst. 1994. PMID: 7932825 Clinical Trial.

7

Schedule-dependent paclitaxel tolerance/activity: data from a 7 day infusion phase I study with pharmacokinetics in paclitaxel refractory ovarian cancer.

Soulié P, Trandafir L, Taamma A, Lokiec F, Brain E, Delord JP, Mita A, Vannetzel JM, Cvitkovic E, Misset JL. Soulié P, et al. Among authors: vannetzel jm. Anticancer Drugs. 1997 Sep;8(8):763-6. doi: 10.1097/00001813-199709000-00005. Anticancer Drugs. 1997. PMID: 9396620 Clinical Trial.

8

Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patients.

Droz JP, Muracciole X, Mottet N, Ould Kaci M, Vannetzel JM, Albin N, Culine S, Rodier JM, Misset JL, Mackenzie S, Cvitkovic E, Benoit G. Droz JP, et al. Among authors: vannetzel jm. Ann Oncol. 2003 Aug;14(8):1291-8. doi: 10.1093/annonc/mdg342. Ann Oncol. 2003. PMID: 12881395 Free article. Clinical Trial.

9

Circadian rhythms in circulating T lymphocyte subtypes and plasma testosterone, total and free cortisol in five healthy men.

Lévi FA, Canon C, Touitou Y, Sulon J, Mechkouri M, Ponsart ED, Touboul JP, Vannetzel JM, Mowzowicz I, Reinberg A, et al. Lévi FA, et al. Among authors: vannetzel jm. Clin Exp Immunol. 1988 Feb;71(2):329-35. Clin Exp Immunol. 1988. PMID: 2964961 Free PMC article.

10

Sequential administration of docetaxel followed by cisplatin-vindesine: a pilot study in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).

Rixe O, Gatineau M, Jauffret E, Spano JP, Orcel B, Vannetzel JM, Berille J, Derenne JP, Khayat D. Rixe O, et al. Among authors: vannetzel jm. Bull Cancer. 2005 Jan;92(1):E1-6. Bull Cancer. 2005. PMID: 15689321 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters